|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1640 EUR | +5.81% |
|
-.--% | - |
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
Revenues | 30.17M | 32.38M | 43.03M | 48.25M | 40.12M | |
Total Revenues | 30.17M | 32.38M | 43.03M | 48.25M | 40.12M | |
Cost of Goods Sold, Total | 12.12M | 30.33M | 51.05M | 32.84M | 41.76M | |
Gross Profit | 18.05M | 2.05M | -8.02M | 15.4M | -1.64M | |
Selling General & Admin Expenses, Total | 10.1M | 24.1M | 20.43M | 15.06M | - | |
Depreciation & Amortization - (IS) | 4.78M | 5.84M | 7.57M | 7.54M | 6.21M | |
Other Operating Expenses, Total | 14.88M | 29.94M | 28M | 22.61M | 6.21M | |
Operating Income | 3.17M | -27.89M | -36.03M | -7.2M | -7.86M | |
Interest Expense, Total | -222K | -759K | -959K | -854K | -700K | |
Interest And Investment Income | 76.86K | - | - | - | 9K | |
Net Interest Expenses | -145K | -759K | -959K | -854K | -691K | |
Currency Exchange Gains (Loss) | -21.43K | -66K | -139K | -58K | -83K | |
Other Non Operating Income (Expenses) | - | - | - | - | -66K | |
EBT, Excl. Unusual Items | 3M | -28.71M | -37.12M | -8.12M | -8.7M | |
Other Unusual Items | 1.27M | - | - | - | - | |
EBT, Incl. Unusual Items | 4.27M | -28.71M | -37.12M | -8.12M | -8.7M | |
Income Tax Expense | 1.03M | -6.51M | -2.28M | 5.35M | 24K | |
Earnings From Continuing Operations | 3.25M | -22.2M | -34.85M | -13.47M | -8.72M | |
Net Income to Company | 3.25M | -22.2M | -34.85M | -13.47M | -8.72M | |
Net Income - (IS) | 3.25M | -22.2M | -34.85M | -13.47M | -8.72M | |
Preferred Dividend and Other Adjustments | - | - | - | -273K | - | |
Net Income to Common Incl Extra Items | 3.25M | -22.2M | -34.85M | -13.2M | -8.72M | |
Net Income to Common Excl. Extra Items | 3.25M | -22.2M | -34.85M | -13.2M | -8.72M | |
Per Share Items | ||||||
Net EPS - Basic | 0.06 | -0.38 | -0.51 | -0.19 | - | |
Basic EPS - Continuing Operations | 0.06 | -0.38 | -0.51 | -0.19 | - | |
Basic Weighted Average Shares Outstanding | 51.67M | 58.83M | 67.71M | 70.83M | - | |
Net EPS - Diluted | 0.06 | -0.38 | -0.51 | -0.19 | - | |
Diluted EPS - Continuing Operations | 0.06 | -0.38 | -0.51 | -0.19 | - | |
Diluted Weighted Average Shares Outstanding | 51.67M | 58.89M | 67.71M | 70.83M | - | |
Normalized Basic EPS | 0.04 | -0.31 | -0.34 | -0.07 | - | |
Normalized Diluted EPS | 0.04 | -0.3 | -0.34 | -0.07 | - | |
Payout Ratio | - | - | - | - | - | |
Supplemental Items | ||||||
EBITDA | 3.32M | -27.7M | -35.78M | -6.98M | -7.63M | |
EBITA | 3.17M | -27.89M | -36.03M | -7.2M | -7.86M | |
EBIT | 3.17M | -27.89M | -36.03M | -7.2M | -7.86M | |
Effective Tax Rate - (Ratio) | 24.02 | 22.67 | 6.13 | -65.95 | -0.28 | |
Total Current Taxes | 44.45K | 67K | 4K | -48K | 24K | |
Total Deferred Taxes | 982K | -6.58M | -2.28M | 4.84M | - | |
Normalized Net Income | 1.87M | -17.95M | -23.2M | -5.07M | -5.43M | |
Interest on Long-Term Debt | 222K | 218K | 664K | 508K | - | |
Supplemental Operating Expense Items | ||||||
Research And Development Expense From Footnotes | 3.63M | 4.12M | 4.26M | 4.79M | 4.64M | |
Stock-Based Comp., Other (Total) | - | 247K | - | - | - | |
Total Stock-Based Compensation | - | 247K | - | - | - |
- Stock Market
- Stocks
- 6EK0 Stock
- Financials SAMM AS
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















